UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, ~~D.C,~~DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) ~~December~~January 912, ~~2015~~2016

Sanomedics, Inc.

(Exact name of registrant as specified in its charter)

Delaware	000-54167	27-3320809
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)
(State or other jurisdictionof incorporation)	(CommissionFile Number)	(IRS EmployerIdentification No.)

444 Brickell Avenue, Suite 415, Miami, Florida		33131
(Address of principal executive offices)		(Zip Code)

Registrant's telephone number, including area code (305) 433-7814

Not applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 31.0201 ~~Unregistered~~Entry ~~Sales~~into ofa ~~Equity~~Material ~~Securities.~~Definitive Agreement

~~From~~Item ~~December 9, 2015 to January 11, 2016 Sanomedics, Inc~~2.03 ~~(the~~Creation ~~"Company") issued a total~~ of ~~100,362,868 shares of common stock to CLSS Holdings, LLC,~~ a ~~company~~Direct ~~owned~~Financial byObligation aor ~~former officer and shareholder of the Company in connection with the conversion of $17,978 in convertible debt held. The recipient is~~ an ~~accredited~~Obligation ~~investor and the issuance was exempt from registration~~ under ~~the~~an ~~Securities~~Off-Balance ~~Act~~Sheet Arrangement of ~~1933 in reliance on exemptions provided by Section 3(~~a~~)(9)~~ ~~of that act.~~Registrant

~~From,~~As ~~December~~previously 9reported, ~~2015~~on toOctober ~~January~~21, 112015, ~~2016~~Sanomedics, Inc. (the "Company ~~issued~~or ~~Redwood~~"Seller") ~~Management~~entered ~~LLC~~into ~~and~~a ~~Redwood~~Stock ~~Fund~~Purchase ~~III,~~Agreement ~~Ltd~~(the ~~combined~~"Purchase aAgreement") ~~total~~with ofPositiveID 29Corporation,~~855,000~~ ~~shares~~a ofDelaware ~~common~~corporation ~~stock~~("PositiveID"), infor ~~connection~~PositiveID ~~with~~to ~~the~~acquire ~~conversion~~all of ~~$17,352~~the inoutstanding ~~convertible~~capital ~~debt~~stock ~~held.~~of ~~The~~Thermomedics, ~~recipient~~Inc., isa anNevada ~~accredited~~corporation ~~investor~~("Thermomedics"), ~~and~~(collectively the ~~issuance~~"Acquisition"). ~~was~~On ~~exempt~~December ~~from~~4, ~~registration~~2015, ~~under~~PositiveID ~~the~~entered ~~Securities~~into ~~Act~~a ofFirst ~~1933~~Amendment into ~~reliance~~the onStock ~~exemptions~~Purchase ~~provided~~Agreement ~~by Section 3~~(~~a)(9)~~the ~~of that act~~"Amendment").

~~From December 9~~PositiveID, ~~2015 to January 11, 2016~~ the ~~Company~~Seller ~~issued~~and ~~unrestricted~~Thermomedics ~~shares~~also ofentered ~~common~~into ~~stock~~a toManagement ~~the~~Services ~~following groups in connection with the conversion of convertible debt held. The recipients are accredited investors~~ and ~~the~~Control ~~issuances~~Agreement, ~~were~~dated ~~exempt~~December ~~from~~4, ~~registration~~2015 ~~under~~ (the ~~Securities~~"Control ~~Act~~Agreement"), ofwhereby ~~1933~~PositiveID inwas ~~reliance~~appointed onas ~~exemptions~~the ~~provided~~manager ~~by Section 3(a)(9)~~ of ~~that~~Thermomedics. ~~act:~~

Lenders	Total SharesIssued		ConvertedDebt
Beaufort Capital Partners LLC		38,436,364	$	22,369
Craig Coaches		7,645,000	$	5,598
May Davis Partners Acquisition Company LLC		19,525,273	$	12,538
Microcap Equity Group LLC		21,711,639	$	12,296
Old Main Capital LLC		37,355,483	$	9,940
Rainman Capital LLC		12,283,000	$	5,898
Rockwell Capital Partners LLC		40,514,000	$	14,998
Steve Carnes		17,300,000	$	2,595

Amendment to Control Agreement

~~From~~On ~~December~~March 94, ~~2015~~2016 the Company and PositiveID entered into an agreement to ~~January~~amend 11and extend for purposes of the Control Agreement, the closing date for delivery of deliverables pursuant to the Purchase Agreement to close by March 31, 2016. In the ~~Company~~event ~~issued~~that asuch ~~total~~transactions close within 20 days of ~~324~~such date,~~988,627~~ ~~shares~~an event of default will be deemed not to ~~all~~occur. Further, an event of default will not be considered to have occurred if the ~~above~~Seller ~~listed~~has ~~groups~~taken inall ~~connection~~necessary ~~with~~steps under the ~~conversion~~Purchase ofAgreement ~~$121,562~~to ofclose ~~convertible~~and ~~debt~~PositiveID ~~held~~elects not to close such transactions.

~~Total~~Additionally ~~convertible~~the ~~debt~~agreement of(i) reaffirmed for the Company ~~from~~to ~~October~~release, 1cancel, ~~2015~~terminate toor ~~January~~otherwise ~~11,~~settle ~~2016~~all ~~has~~intercompany ~~decreased~~indebtedness ~~$549,576~~and ~~with~~accounts owed by or to Thermomedics to or by the ~~conversion~~Company or any of ~~convertible~~its ~~debt~~affiliates ~~held~~as of December 4, 2015 and ~~issuance~~(ii) provided for the transfer of ~~339~~all Patents and other Intellectual Property in its name that were included in the schedules to the Purchase Agreement dated October 21,~~168,471~~ ~~shares~~2015.

~~Item~~The 7foregoing description of the terms of the Amendment to the Control Agreement, do not purport to be complete and are qualified in their entirety by reference to the provisions of such agreements forms of which are filed as exhibit 10.0196 ~~Regulation~~to FDthis ~~Disclosure~~Current Report on Form 8-K.

OnItem ~~January 14, 2016, Sanomedics, Inc~~3.02 ~~issued~~Unregistered aSales ~~press release announcing the conversion~~ of ~~debt.~~Equity ~~A copy of the release is furnished as Exhibit 99.1 to this report.~~Securities

~~Pursuant~~From toJanuary ~~General~~12, ~~Instruction~~2016 ~~B.2~~to ofMarch ~~Form~~3, ~~8-K~~2016 Sanomedics, Inc. (the ~~information~~"Company") ~~appearing~~issued ina ~~this~~total ~~Form~~of ~~8-K~~51,918,499 ~~including~~shares ~~Exhibit~~of ~~99.1,~~common isstock ~~being~~to ~~furnished~~CLSS ~~and~~Holdings, ~~shall~~LLC, ~~not~~a becompany ~~deemed~~owned ~~filed~~by ~~for~~a ~~the~~former ~~purposes~~officer ofand ~~Section~~shareholder 18 of the ~~Securities~~Company ~~Exchange~~in ~~Act~~connection ofwith ~~1934~~the orconversion ~~otherwise~~of be$2,365 ~~subject~~in toconvertible ~~the~~debt ~~liabilities~~held. ofThe ~~that~~recipient ~~section, nor~~ is itan ~~incorporated~~accredited byinvestor ~~reference~~and ~~into~~the ~~any~~issuance ~~filing~~was ofexempt ~~Sanomedics,~~from ~~Inc.~~registration under the Securities Act of 1933 orin ~~the~~reliance ~~Securities~~on ~~Exchange~~exemptions ~~Act~~provided ofby ~~1934,~~Section ~~whether~~3(a)(9) ~~made before or after the date hereof, regardless~~ of ~~any~~that ~~general incorporation language in such filing~~act.

~~Item 9.01 Financial Statements and Exhibits.~~2

From January 12, 2016 to March 3, 2016 the Company issued Redwood Management LLC a total of 61,190,000 shares of common stock in connection with the conversion of $5,104 in convertible debt held. The recipient is an accredited investor and the issuance was exempt from registration under the Securities Act of 1933 in reliance on exemptions provided by Section 3(da)(9) ~~Exhibits~~of that act.

Exhibit No.		Description
99.1		Press release dated January 14, 2016.

FromJanuary 12, 2016 to March 3, 2016 the Company issued unrestricted shares of common stock to the following groups in connection with the conversion of convertible debt held. The recipientsare accredited investors and the issuances were exempt from registration under the Securities Act of 1933 in reliance on exemptions provided by Section 3(a)(9) of that act:

Lenders	Total Shares Issued		Converted Debt
Beaufort Capital Partners LLC		112,409,545	$	8,134
May Davis Partners Acquisition Company LLC		24,897,765	$	1,556
Microcap Equity Group LLC		58,700,200	$	4,325
Old Main Capital LLC		61,954,719	$	6,000
Rainman Capital LLC		75,300,000	$	5,437
Vis Vires Group		48,875,000	$	3,910
Steve Carnes		17,300,000	$	2,595

~~SIGNATURES~~From January 12, 2016 to March 3, 2016the Company issued a total of 512,545,728 shares to all of the above listed groups in connection with the conversion of $39,426 of convertible debt held.

~~Pursuant~~Item to9.01 ~~the~~Financial ~~requirements~~Statements ofand ~~the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.~~Exhibit

	Sanomedics, Inc.
ExhibitNumber		Description
Date: January 15, 2016	By:	/s/ David C. Langle
10.96		Management Services and Control Agreement, dated March 4, 2016, by and between PositiveID Corporation and Sanomedics Inc.
		David C. Langle
		Chief Executive Officer & Chief Financial Officer

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Sanomedics International Holdings, Inc.

Date: March 14, 2016	By:	/s/ David C. Langle
		David C. Langle
		Chief Executive Officer & Chief Financial Officer

Filing Compare · Sanomedics, Inc.